The Role of Finerenone in the Management of Diabetic Nephropathy

Veneti, S; Tziomalos, K

Tziomalos, K (corresponding author), Aristotle Univ Thessaloniki, Propedeut Dept Internal Med 1, Med Sch, AHEPA Hosp, 1 Stilponos Kyriakidi St, Thessaloniki 54636, Greece.

DIABETES THERAPY, 2021; 12 (7): 1791

Abstract

Diabetic nephropathy (DN) is the leading cause of chronic kidney disease. Even though mineralocorticoid receptor antagonists (MRA) induce incremental ......

Full Text Link